ATE271390T1 - Verwendung von azithromycin zur topischen behandlung von augeninfektionen - Google Patents

Verwendung von azithromycin zur topischen behandlung von augeninfektionen

Info

Publication number
ATE271390T1
ATE271390T1 AT98309274T AT98309274T ATE271390T1 AT E271390 T1 ATE271390 T1 AT E271390T1 AT 98309274 T AT98309274 T AT 98309274T AT 98309274 T AT98309274 T AT 98309274T AT E271390 T1 ATE271390 T1 AT E271390T1
Authority
AT
Austria
Prior art keywords
azithromycin
topical treatment
eye infections
treatment
infections
Prior art date
Application number
AT98309274T
Other languages
English (en)
Inventor
Imran Ahmed
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22074743&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE271390(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of ATE271390T1 publication Critical patent/ATE271390T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
AT98309274T 1997-12-02 1998-11-12 Verwendung von azithromycin zur topischen behandlung von augeninfektionen ATE271390T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6725097P 1997-12-02 1997-12-02

Publications (1)

Publication Number Publication Date
ATE271390T1 true ATE271390T1 (de) 2004-08-15

Family

ID=22074743

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98309274T ATE271390T1 (de) 1997-12-02 1998-11-12 Verwendung von azithromycin zur topischen behandlung von augeninfektionen

Country Status (11)

Country Link
EP (1) EP0925789B2 (de)
JP (1) JPH11240838A (de)
AT (1) ATE271390T1 (de)
BR (1) BR9805318A (de)
CA (1) CA2254682C (de)
CY (1) CY1105482T1 (de)
DE (1) DE69825128T3 (de)
DK (1) DK0925789T4 (de)
ES (1) ES2221127T5 (de)
MX (1) MX232591B (de)
PT (1) PT925789E (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861411B1 (en) 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
US7056893B2 (en) 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
IT1313610B1 (it) * 1999-08-09 2002-09-09 S I F I Societa Ind Farmaceuti Processo per la preparazione di formulazioni acquose per uso oftalmico
DE10006560A1 (de) 2000-02-15 2001-08-23 Disetronic Licensing Ag Zweikomponentiger Kolbenstopfen
IL141438A0 (en) * 2000-02-23 2002-03-10 Pfizer Prod Inc Method of increasing the bioavailability and tissue penetration of azithromycin
EP1563850A3 (de) * 2000-02-23 2008-02-20 Pfizer Products Inc. Verfahren zur Erhöhung der Bioverfügbarkeit und dem Eindringen in Gefässe von Azithromycin
FR2823441B1 (fr) * 2001-04-12 2004-09-10 Thea Lab Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation
SI1390377T1 (sl) 2001-05-22 2006-06-30 Pfizer Prod Inc Nova kristalna oblika azitromicina
US7807802B2 (en) 2002-11-12 2010-10-05 Abbott Lab Polynucleotides for the amplification and detection of Chlamydia trachomatis and Neisseria gonorrhoeae
EP1691786A1 (de) 2003-12-04 2006-08-23 Pfizer Products Inc. Multiteilchenförmige zusammensetzungen mit verbesserter stabilität
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
SI1691787T1 (sl) 2003-12-04 2008-10-31 Pfizer Prod Inc Postopek za pripravo farmacevtskih produktov iz več delcev
ATE529117T1 (de) 2004-07-02 2011-11-15 Wakamoto Pharma Co Ltd Medizinische zusammensetzung auf wasserbasis mit azithromycin und herstellungsverfahren dafür
US20060046970A1 (en) * 2004-08-31 2006-03-02 Insite Vision Incorporated Topical otic compositions and methods of topical treatment of prevention of otic infections
FR2884716B1 (fr) * 2005-04-22 2009-08-21 Thea Sa Lab Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires
JPWO2007074904A1 (ja) * 2005-12-28 2009-06-04 わかもと製薬株式会社 水性医薬組成物
US20100247666A1 (en) * 2009-03-24 2010-09-30 Macleod Steven K Method for Preparing Suspensions of Low-Solubility Materials
US9775802B2 (en) 2009-03-24 2017-10-03 Bausch & Lomb Incorporated Method for preparing suspensions of low-solubility materials

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
AU7957994A (en) * 1993-10-01 1995-05-01 Procter & Gamble Company, The Use of azithromycin for the treatment of adult periodontitis and topical compositions for this use
US5610198A (en) † 1994-03-18 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services Anti-mycobacterial compositions and their use for the treatment of tuberculosis and related diseases
AU4399396A (en) * 1994-12-19 1996-07-10 Russinsky Limited Compounds
US5872104A (en) * 1994-12-27 1999-02-16 Oridigm Corporation Combinations and methods for reducing antimicrobial resistance
DE69634277T2 (de) † 1995-06-07 2006-01-05 Southern Biosystems, Inc., Birmingham Kontrolliertes zuführsystem mit einer flüssigkeit von hoher viskosität

Also Published As

Publication number Publication date
CA2254682A1 (en) 1999-06-02
MX232591B (es) 2005-12-02
DK0925789T3 (da) 2004-10-25
EP0925789B2 (de) 2009-06-17
DE69825128T3 (de) 2010-05-06
DE69825128T2 (de) 2005-07-28
CA2254682C (en) 2003-07-08
DE69825128D1 (de) 2004-08-26
DK0925789T4 (da) 2009-07-13
JPH11240838A (ja) 1999-09-07
EP0925789B1 (de) 2004-07-21
ES2221127T5 (es) 2009-11-10
CY1105482T1 (el) 2010-04-28
ES2221127T3 (es) 2004-12-16
BR9805318A (pt) 2000-04-11
PT925789E (pt) 2004-10-29
EP0925789A1 (de) 1999-06-30

Similar Documents

Publication Publication Date Title
ATE271390T1 (de) Verwendung von azithromycin zur topischen behandlung von augeninfektionen
ATE202706T1 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
IL148079A0 (en) Human ctla-4 antibodies and compositions containing the same
DE69907664D1 (de) Verfahren zur Herstellung von wässrigen Formulierungen für ophthalmische Verwendung
ATE222744T1 (de) Formulierungen und verfahren zur reduzierung von hautreizung
PT842934E (pt) Agonistas de 5-ht1f
ATE179610T1 (de) Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten
GB9908934D0 (en) Liquid crystalline compounds
DE69626539D1 (de) topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen
DE69912972D1 (de) Antibiotische zusammensetzungen zur behandlung des auges
ES2194960T3 (es) N-(2-sustituido-3-(2-aminoetil)-1h-indol-5-il)-amidas como nuevos agonistas de 5-ht1f.
ATE254461T1 (de) Behandlung von augenschmerzen
ATE238792T1 (de) Verwendung von makroliden zur behandlung von glaukom
DE69106586D1 (de) Verwendung von Baclofen zur Herstellung von Arzneimitteln zur Behandlung von Angina pectoris.
DE69924375D1 (de) Verwendung von optisch reinem (+)-norcisapride für die behandlung des reizdarmsyndroms
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
DE69612465D1 (de) Verwendung von Rifamyciderivaten zur Behandlung von Chlamydia-Infektionen
DE69835536D1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
ES2191075T3 (es) 8-arilalquil- y 8-arilheteroalquil-5,11-dihidro-6h-dipirido-(3,2-b:2',3'-e)(1,4)diazepinas y su uso en la prevencion o tratamiento de infecciones por hiv.
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
DE69617005D1 (de) 2-amino-benzoxazinone zur behandlung von viralen infektionen
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
ID25478A (id) Agonis 5-ht1f
DE69810724D1 (de) Verwendung von Protein C Inhibitor zur Behandlung disseminierter intravasaler Gerinnung (DIC)
BR9808210A (pt) Befeniloxazolinas dissubstituìdas

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0925789

Country of ref document: EP

UEP Publication of translation of european patent specification

Ref document number: 0925789

Country of ref document: EP